Indivior PLC — Director's Dealing 2026

Jan 28, 2026

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Indivior Pharmaceuticals, Inc. (INDV)
CIK: 0001625297
Period of Report: 2026-01-26

Reporting Person: Ryan Barbara (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2026-01-26	Common Stock	A	3722	—	Acquired	5685	Direct

Footnotes

F1: Reflects a grant of Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest on the day immediately preceding the date of the first annual meeting of the Issuer's stockholders following the date of grant, subject to the Reporting Person's continued service to the Issuer on the vesting date.